2025. Design and Optimization of Dual-Drug Nanocarriers for Targeted Management of Diabetic Neuropathy (Pregabalin + Alpha-Lipoic Acid): A Quality by Design Approach. Vascular and Endovascular Review. 8, 19s (Dec. 2025), 18–29. DOI:https://doi.org/10.64149/J.Ver.8.19s.18-29.